ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3000

Safety of the Knee Needle Arthroscopy: A Review of 1136 Procedures in 919 Patients

Alla ISHCHENKO1, Jean-cyr YOMBI2 and Adrien Nzeusseu Toukap3, 1Rheumatology, Cliniques universitaires Saint-Luc, Brussels, Belgium, 2Internal Medicine, IREC/Cliniques universitaires St-Luc/Faculté de médecine/Université Catholique de Louvain, Brussels, Belgium, 3Pôle de Maladies Rhumatismales, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Arthroscopy and infection

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Orthopedics, Low Back Pain and Rehabilitation

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Knee needle arthroscopy (KNA) is a minimally invasive procedure consisting in insertion of a thin fiber-optic needle system in the joint cavity, followed by inspection, tissue sampling, therapeutic lavage, and if needed, steroids injection after the procedure. It is usually performed in an office-based setting, requiring only local anaesthesia, as an out-patient procedure. KNA is of particular interest as it can be used for diagnosis (in case of undifferenciated arthritis), scientific purposes (synovial biopsies serving for histology, proteomics, and genomics), and can serve as a therapeutic tool (mainly articular lavage). Few data have been published regarding safety of KNA, and available studies deal with a relatively small number of patients. Objective: To determine the incidence of overall and serious, notably septic, complications, and identify patients at higher risk.

Methods: We retrospectively reviewed the records of all arthroscopies performed in the rheumatology department of our teaching hospital between July 2002 and December 2015. Patients, suffering from a rheumatic disease, and knee complains underwent a KNA, either for the diagnosis, or for clinical research reason. The procedure was performed in a dedicated room under sterile conditions (extensive local disinfection and draping of the leg) and local anaesthesia, by a senior rheumatologist. Of note, joint needle aspiration was performed before the incision. The fluid (if obtained) was then sent for routine laboratory analysis: cellularity, crystal detection and culture. The patient was allowed to walk immediately after the procedure. All patients signed an informed consent before the procedure.

Results: A total of 919 patients were included in the study. Two-thirds (65.4%) were female and mean age was 52 years. A total of 1,136 KNA were performed. Almost half of the patients suffered from rheumatoid arthritis (47%), 20.2% from osteoarthritis, 10.7% from spondylarthritis, 10.7% from undifferentiated arthritis, 4.9% from microcrystalline arthritis, 3% from connective tissue diseases, and 1.8% from idiopathic juvenile arthritis A few patients suffered from sarcoidosis, hemochromatosis, villonodular synovitis and polymyalgia rheumatica. Of note, a diagnosis of septic arthritis was suspected in 7 patients by joint inspection and confirmed by positive cultures. The overall rate of complications was 1.5% and the rate of infection was 0.79%. Minor complications included 2 cases of subcutaneous hematoma, 4 cases of delayed healing with persistent superficial wound, 1 case of local skin atrophy after glucocorticoids (GC) injection and 1 case of pancreatitis, also attributed to the injection of GC in a HIV positive patient, treated with antiretrovirals. We observed no cases of post-intervention hemarthrosis, bleeding or thrombo-embolic complications. All serious complications were infectious. We identified 7 cases of confirmed septic arthritis, 1 case of septic bursitis and 1 case of possible septic arthritis (no bacteriological proof). Patients were predominantly male (6/9), most of them with ≥2 comorbidities. 4 out of 9 patients were treated by oral GC and all patients received intraarticular glucocorticoids during the procedure. As expected, Staphylococcus aureuswas the most frequent pathogen identified. On the 9 infected patients, 7 were hospitalized, treated with IV antibiotics and underwent a surgical arthroscopic lavage 24-48 hours following the admission. Clinical evolution showed improvement in all cases with no long-term morbidity.

Conclusion:

KNA is a safe, and well-tolerated procedure, with less than 1% of septic complications. It’s slightly lower than conventional arthroscopy, with the additional advantages of local anaesthesia, fast recovery and lower cost. Special caution should be applied to patients with comorbidities, previous infection, or treated with GC.


Disclosure: A. ISHCHENKO, None; J. C. YOMBI, None; A. Nzeusseu Toukap, None.

To cite this abstract in AMA style:

ISHCHENKO A, YOMBI JC, Nzeusseu Toukap A. Safety of the Knee Needle Arthroscopy: A Review of 1136 Procedures in 919 Patients [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/safety-of-the-knee-needle-arthroscopy-a-review-of-1136-procedures-in-919-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/safety-of-the-knee-needle-arthroscopy-a-review-of-1136-procedures-in-919-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology